Document is current
Any future updates will be listed below
-
Authors
Polai, Zsofia https://orcid.org/0000-0003-3745-026X
Kajdacsi, Erika
Cervenak, Laszlo
Balla, Zsuzsanna
Benedek, Szabolcs
Varga, Lilian
Farkas, Henriette
-
Funding
Funding for this research was provided by:
Nemzeti Kutatási Fejlesztési és Innovációs Hivatal (124557)
Semmelweis University
- License Information
-
More Information
Article History
Received: 26 January 2022
Accepted: 23 January 2023
First Online: 1 February 2023
Declarations
:
: The study protocol was approved by the institutional review board of Semmelweis University of Budapest, Informed consent was obtained from the participants in accordance with the Declaration of Helsinki.
: Not applicable.
: H. Farkas has received honoraria and travel grants from CSL Behring, Shire/Takeda, Swedish Orphan Biovitrum, Octapharma, Kalvista and Pharming; and/or served as a consultant for these companies and has participated in clinical trials/ registries for BioCryst, CSL Behring, Pharming, Pharvaris and Shire. Zs. Balla has participated in clinical trials of CSL Behring, Pharvaris and Takeda. The other authors have declared that no conflict of interest exists.
